0

Coagulopathies Collection
 1-20 of 262 Articles
Articles |  3 March 2009
Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin: A Randomized Trial
Mark A. Crowther, MD, MSc; Walter Ageno, MD; David Garcia, MD; et al.
Ann Intern Med. 2009;150(5):293-300. doi:10.7326/0003-4819-150-5-200903030-00005
Reviews |  2 January 2007
Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura
Donald M. Arnold, MD, MSc; Francesco Dentali, MD; Mark A. Crowther, MD, MSc; et al.
Ann Intern Med. 2007;146(1):25-33. doi:10.7326/0003-4819-146-1-200701020-00006
Articles |  5 April 2005
Brief Communication: Duration of Platelet Dysfunction after a 7-Day Course of Ibuprofen
Neil A. Goldenberg, MD; Linda Jacobson, MT; Marilyn J. Manco-Johnson, MD
Ann Intern Med. 2005;142(7):506-509. doi:10.7326/0003-4819-142-7-200504050-00009
Reviews |  20 January 2004
Management of Adult Patients with Persistent Idiopathic Thrombocytopenic Purpura Following Splenectomy: A Systematic Review
Sara K. Vesely, PhD; Jedidiah J. Perdue, MPH; Mujahid A. Rizvi, MD, MPH; et al.
Ann Intern Med. 2004;140(2):112-120. doi:10.7326/0003-4819-140-3-200402030-00012
Articles |  16 September 2003
The Rate of Progression to Polycythemia Vera or Essential Thrombocythemia in Patients with Erythrocytosis or Thrombocytosis
Marco Ruggeri, MD; Alberto Tosetto, MD; Maurizio Frezzato, MD; et al.
Ann Intern Med. 2003;139(6):470-475. doi:10.7326/0003-4819-139-6-200309160-00009
Academia and the Profession |  4 February 2003
Screening for the Risk for Bleeding or Thrombosis
Mark H. Eckman, MD; John K. Erban, MD; Sushil K. Singh, MD; et al.
Ann Intern Med. 2003;138(3):W-15–W-24. doi:10.7326/0003-4819-138-3-200302040-00011-w1
Editorials |  21 January 2003
Thrombotic Thrombocytopenic Purpura: From the Bench to the Bedside, but Not Yet to the Community
James N. George, MD; Sara K. Vesely, PhD
Ann Intern Med. 2003;138(2):152-153. doi:10.7326/0003-4819-138-2-200301210-00018
Brief Communications |  21 January 2003
Remission of Chronic Thrombotic Thrombocytopenic Purpura after Treatment with Cyclophosphamide and Rituximab
Xinglong Zheng, MD, PhD; Arnel M. Pallera, MD; Lawrence T. Goodnough, MD; et al.
Ann Intern Med. 2003;138(2):105-108. doi:10.7326/0003-4819-138-2-200301210-00011
Brief Communications |  3 December 2002
Reversal of Warfarin-Induced Excessive Anticoagulation with Recombinant Human Factor VIIa Concentrate
Ruby Anne E. Deveras, MD; Craig M. Kessler, MD
Ann Intern Med. 2002;137(11):884-888. doi:10.7326/0003-4819-137-11-200212030-00009
Brief Communications |  20 August 2002
Oral Vitamin K Lowers the International Normalized Ratio More Rapidly Than Subcutaneous Vitamin K in the Treatment of Warfarin-Associated Coagulopathy: A Randomized, Controlled Trial
Mark A. Crowther, MD, MSc; James D. Douketis, MD; Terri Schnurr, RN; et al.
Ann Intern Med. 2002;137(4):251-254. doi:10.7326/0003-4819-137-4-200208200-00009
Brief Communications |  5 February 2002
Delayed-Onset Heparin-Induced Thrombocytopenia
Lawrence Rice, MD; Walid K. Attisha, MD; Alane Drexler, MS, RN; et al.
Ann Intern Med. 2002;136(3):210-215. doi:10.7326/0003-4819-136-3-200202050-00009
Brief Communications |  18 December 2001
Quinine-Associated Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome: Frequency, Clinical Features, and Long-Term Outcomes
Kiarash Kojouri, MD, MPH; Sara K. Vesely, PhD; James N. George, MD
Ann Intern Med. 2001;135(12):1047-1051. doi:10.7326/0003-4819-135-12-200112180-00008
Brief Communications |  2 October 2001
Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis
Theodore E. Warkentin, MD; John G. Kelton, MD
Ann Intern Med. 2001;135(7):502-506. doi:10.7326/0003-4819-135-7-200110020-00009
Brief Communications |  16 May 2000
Antibody Inhibitors to von Willebrand Factor Metalloproteinase and Increased Binding of von Willebrand Factor to Platelets in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura
Han-Mou Tsai, MD; Lawrence Rice, MD; Ravindra Sarode, MD; et al.
Ann Intern Med. 2000;132(10):794-799. doi:10.7326/0003-4819-132-10-200005160-00005
Reviews |  1 December 1998
Drug-Induced Thrombocytopenia: A Systematic Review of Published Case Reports
James N. George, MD; Gary E. Raskob, MSc; Shehla Rizvi Shah, MD; et al.
Ann Intern Med. 1998;129(11_Part_1):886-890. doi:10.7326/0003-4819-129-11_Part_1-199812010-00009
Brief Communications |  1 April 1998
Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine: A Review of 60 Cases
Charles L. Bennett, MD, PhD; Peter D. Weinberg, BS; Karine Rozenberg-Ben-Dror, PharmD; et al.
Ann Intern Med. 1998;128(7):541-544. doi:10.7326/0003-4819-128-7-199804010-00004
Articles |  1 January 1998
Clarification of the Risk for Venous Thrombosis Associated with Hereditary Protein S Deficiency by Investigation of a Large Kindred with a Characterized Gene Defect
Rachel E. Simmonds, PhD; Helen Ireland, PhD; David A. Lane, PhD; et al.
Ann Intern Med. 1998;128(1):8-14. doi:10.7326/0003-4819-128-1-199801010-00002
Articles |  1 November 1997
The Pathogenesis of Venous Limb Gangrene Associated with Heparin-Induced Thrombocytopenia
Theodore E. Warkentin, MD; Leela J. Elavathil, MBBS; Catherine P.M. Hayward, MD; et al.
Ann Intern Med. 1997;127(9):804-812. doi:10.7326/0003-4819-127-9-199711010-00005
Brief Communications |  1 August 1997
Successful Treatment of Acquired Hemophilia with Oral Immunosuppressive Therapy
Linda G. Shaffer, MD; Martin D. Phillips, MD
Ann Intern Med. 1997;127(3):206-209. doi:10.7326/0003-4819-127-3-199708010-00005
Articles |  1 August 1997
Monitoring Warfarin Therapy in Patients with Lupus Anticoagulants
Stephan Moll, MD; Thomas L. Ortel, MD, PhD
Ann Intern Med. 1997;127(3):177-185. doi:10.7326/0003-4819-127-3-199708010-00001
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)